TEM Acquires Personalis

On the strategic front, TEM announced a planned acquisition of Personalis (NASDAQ:PSNL) in a 100 % stock transaction valuing Personalis at $1.5 billion net of TEM’s existing ownership, with an offer price of $16.25 per share—representing a 6 % premium to the Friday close and a 28 % premium to the 30‑day VWAP. The deal is expected to close in late 2026 or early 2027 and is structured with an option for TEM to pay up to 50 % in cash. Personalis currently reports preliminary second‑quarter revenue of $22.4 million and has delivered 10,384 MRD tests, a 33 % increase from the prior quarter, although it is operating at a net loss.